How is the RAPT Therapeutics Inc today?

The RAPT Therapeutics Inc today is trading in the green, up by 1.78% at 9.73.

How has RAPT Therapeutics Inc performed historically?

The RAPT Therapeutics Inc is currently trading up 1.78% on an intraday basis in the past week the index rose 31.13%. The index has been down -16.12% in the past quarter and fell -60.12% in the past year. You can view this in the overview section.

What is RAPT Therapeutics Inc Annual Net Profit?

RAPT Therapeutics Inc Annual Net Profit fell 11.19% in the last year to $129.86 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is RAPT Therapeutics Inc Price to Earning Ratio?

RAPT Therapeutics Inc Price to Earning Ratio is -1.38, which is negative.

What is RAPT Therapeutics Inc Stock Price?

RAPT Therapeutics Inc Stock Price fell 60.12% and underperformed its sector by 107% in the past year.

What is RAPT Therapeutics Inc Quarterly Net profit?

RAPT Therapeutics Inc Quarterly Net profit rose 43.76% YoY to $17.16 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is RAPT Therapeutics Inc Debt to Equity Ratio?

RAPT Therapeutics Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is RAPT Therapeutics Inc Return on Equity(ROE)?

RAPT Therapeutics Inc Return on Equity(ROE) for the last financial year was -77.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is RAPT Therapeutics Inc Mutual Fund Holding?

RAPT Therapeutics Inc Mutual Fund Holding increased by 3.44% in the last quarter to 13.38.

What is RAPT Therapeutics Inc Promoter Share Holding?

RAPT Therapeutics Inc Promoter Share Holding stayed the same in the most recent quarter at 0.78%.

What is RAPT Therapeutics Inc Institutional Holding?

RAPT Therapeutics Inc Institutional Holding increased by 5.96% in the last quarter to 85.16.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
RAPT THERAPEUTICS INC

RAPT Therapeutics Inc XNAS: RAPT

RAPT Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: RAPT Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: RAPT Therapeutics Inc
Rating: 1.58916675
Author: Trendlyne DVM scores

about

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases...

9.73 0.17 (1.78%)

68.20% Fall from 52W High

119.3K

XNAS Volume

XNAS 26 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.2 / 100

Technically Neutral

51.4 / 100

No estimates available

RAPT Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

RAPT Therapeutics Inc Live Share Price Today, Share Analysis and Chart

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases...

68.20% Fall from 52W High

SWOT Analysis

RAPT Therapeutics Inc Live Price Chart

RAPT Therapeutics Inc FAQ

How is RAPT Therapeutics Inc today?

RAPT Therapeutics Inc today is trading in the green, and is up by 1.78% at 9.73.

How has RAPT Therapeutics Inc performed historically?

RAPT Therapeutics Inc is currently trading up 1.78% on an intraday basis. In the past week the stock rose 31.13%. stock has been down -16.12% in the past quarter and fell -60.12% in the past year. You can view this in the overview section.